The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services, has awarded IDT Biologika a 10-year Indefinite Quantity, Indefinite Delivery (IDIQ) contract. IDT will provide process development, manufacturing and characterization of vaccine and biologic products for infectious diseases. The total funding could be up to $80 million over the course of the contract if all project milestones...